Skip to main content

Clinical Trials › NCT04267926

Active, Not RecruitingPhase 1

MitoQ for Fatigue in Multiple Sclerosis (MS)

Sponsored by VA Office of Research and Development

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
45
Target enrollment
1
U.S. states
Apr 2020
Start date
Mar 2026
Expected completion

Interventions / Treatments

20 mg MitoQPlacebo40mg of MitoQ

Conditions studied

Multiple Sclerosis

Where this trial is running (1 site)

Oregon1 site
Portland

MS centers in Oregon

Compare treatment centers near a trial site by center type, providers and trials.

View Oregon centers

More Phase 1 trials

Browse all Phase 1 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play